Medtronic plc MDT recently announced three-month favorable results from an on-label, prospective, multi-center study showing meaningful pain relief using DTM SCS endurance therapy. Notably, DTM SCS ...
Medtronic plc MDT continues to grab headlines with recent breakthroughs within its neuromodulation line. Following last week’s FDA approval of SenSight Directional Lead System, this time the company ...
Spinal cord stimulators deliver mild electrical impulses to the spinal cord, which can disrupt pain signals before they reach the brain. As patients go about their daily lives, certain movements may ...
Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain DUBLIN, April 26, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare ...
How Medtronic spinal cord stimulation therapy helped one woman reclaim her life. For more than a decade, Lynnette lived in the shadow of debilitating pain. What began as persistent discomfort in her ...
Credit: Getty Images. These SCS devices were cleared based on data from a randomized controlled trial published in the journal Diabetes Care in 2014. The Food and Drug Administration (FDA) has ...
Medtronic plc MDT continues to grab headlines with recent breakthroughs within its neuromodulation line. Following last week’s FDA approval of SenSight Directional Lead System, this time the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback